Los Angeles Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-8,846
| Closed | -$602K | – | 1316 |
|
|
2022
Q3 | $602K | Buy |
+8,846
| New | +$602K | ﹤0.01% | 862 |
|
|
2021
Q1 | – | Sell |
-7,394
| Closed | -$320K | – | 1678 |
|
|
2020
Q4 | $320K | Sell |
7,394
-22,925
| -76% | -$992K | ﹤0.01% | 1350 |
|
|
2020
Q3 | $1.67M | Sell |
30,319
-134,448
| -82% | -$7.41M | 0.01% | 620 |
|
|
2020
Q2 | $10.4M | Buy |
164,767
+148,038
| +885% | +$9.35M | 0.05% | 265 |
|
|
2020
Q1 | $855K | Buy |
16,729
+664
| +4% | +$33.9K | 0.01% | 753 |
|
|
2019
Q4 | $1.28M | Hold |
16,065
| – | – | 0.01% | 763 |
|
|
2019
Q3 | $779K | Hold |
16,065
| – | – | ﹤0.01% | 872 |
|
|
2019
Q2 | $845K | Sell |
16,065
-8,990
| -36% | -$473K | ﹤0.01% | 889 |
|
|
2019
Q1 | $1.33M | Sell |
25,055
-90
| -0.4% | -$4.76K | 0.01% | 765 |
|
|
2018
Q4 | $1.03M | Sell |
25,145
-8,155
| -24% | -$335K | 0.01% | 728 |
|
|
2018
Q3 | $1.27M | Sell |
33,300
-39,000
| -54% | -$1.48M | 0.01% | 788 |
|
|
2018
Q2 | $3.27M | Buy |
72,300
+65,320
| +936% | +$2.95M | 0.02% | 571 |
|
|
2018
Q1 | $337K | Buy |
+6,980
| New | +$337K | ﹤0.01% | 1152 |
|